Elekta (OTCMKTS:EKTAY) Sees Unusually-High Trading Volume – Here’s What Happened

Elekta AB (OTCMKTS:EKTAY) saw strong trading volume on Monday . Approximately 3,119 shares changed hands during mid-day trading, an increase of 14% from the previous session’s volume of 2,725 shares.The stock last traded at $4.94 and had previously closed at $4.7704.

Analyst Upgrades and Downgrades

Separately, Zacks Research downgraded Elekta from a “hold” rating to a “strong sell” rating in a research note on Tuesday, June 2nd. Two analysts have rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.

Elekta Trading Up 3.5%

The firm has a market cap of $1.82 billion, a price-to-earnings ratio of -30.84 and a beta of 1.01. The company’s 50-day moving average price is $5.39 and its 200-day moving average price is $5.88. The company has a quick ratio of 0.68, a current ratio of 0.87 and a debt-to-equity ratio of 0.47.

Elekta (OTCMKTS:EKTAY) last issued its quarterly earnings results on Thursday, May 28th. The company reported $0.06 earnings per share for the quarter. The firm had revenue of $521.00 million for the quarter. Elekta had a negative net margin of 3.32% and a positive return on equity of 11.11%. Equities analysts expect that Elekta AB will post 0.43 EPS for the current fiscal year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.